Measurement of the human esophageal cancer in an early stage with Raman spectroscopy

Yasuhiro Maeda; Mika Ishigaki; Akinori Taketani; Bibin B. Andriana; Ryu Ishihara; Hidetoshi Sato

doi:10.1117/12.2038975

28 February 2014 Measurement of the human esophageal cancer in an early stage with Raman spectroscopy

Yasuhiro Maeda, Mika Ishigaki, Akinori Taketani, Bibin B. Andriana, Ryu Ishihara, Hidetoshi Sato

Proceedings Volume 8951, Optical Diagnostics and Sensing XIV: Toward Point-of-Care Diagnostics; 89510N (2014) https://doi.org/10.1117/12.2038975
Event: SPIE BiOS, 2014, San Francisco, California, United States

Abstract

The esophageal cancer has a tendency to transfer to another part of the body and the surgical operation itself sometimes gives high risk in vital function because many delicate organs exist near the esophagus. So the esophageal cancer is a disease with a high mortality. So, in order to lead a higher survival rate five years after the cancer’s treatment, the investigation of the diagnosis methods or techniques of the cancer in an early stage and support the therapy are required. In this study, we performed the ex vivo experiments to obtain the Raman spectra from normal and early-stage tumor (stage-0) human esophageal sample by using Raman spectroscopy. The Raman spectra are collected by the homemade Raman spectrometer with the wavelength of 785 nm and Raman probe with 600-um-diameter. The principal component analysis (PCA) is performed after collection of spectra to recognize which materials changed in normal part and cancerous pert. After that, the linear discriminant analysis (LDA) is performed to predict the tissue type. The result of PCA indicates that the tumor tissue is associated with a decrease in tryptophan concentration. Furthermore, we can predict the tissue type with 80% accuracy by LDA which model is made by tryptophan bands.

Citation Download Citation

Yasuhiro Maeda, Mika Ishigaki, Akinori Taketani, Bibin B. Andriana, Ryu Ishihara, and Hidetoshi Sato "Measurement of the human esophageal cancer in an early stage with Raman spectroscopy", Proc. SPIE 8951, Optical Diagnostics and Sensing XIV: Toward Point-of-Care Diagnostics, 89510N (28 February 2014); https://doi.org/10.1117/12.2038975

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available